Committee Lens Primary Health and Retirement Security
— committee · oversees Health
Trades by this committee's members in the sector(s) it oversees — the committee's conflict surface — ranked by Conflict Score. How it's scored.
41
Flagged trades
1 / 1
Members trading in-jurisdiction
$499,520
Est. disclosed volume
77/100
Worst conflict score
Who's trading in-jurisdiction
| Conflict | Member | Ticker | Company | Type | Date | Amount | Sector | Source |
|---|---|---|---|---|---|---|---|---|
| 77 | Alan Armstrong | JNJ | Johnson & Johnson | BUY | 2026-03-27 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | SNY | Sanofi | BUY | 2026-03-30 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | NVO | Novo Nordisk A S | BUY | 2026-03-30 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | NVS | Novartis AG | BUY | 2026-03-30 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | GSK | Gsk plc | BUY | 2026-03-30 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | AZN | Astrazeneca plc | BUY | 2026-03-30 | $15K–$50K | Health | ↗ eFD |
| 77 | Alan Armstrong | ABBV | Abbvie Inc. | BUY | 2026-03-27 | $15K–$50K | Health | ↗ eFD |
| 75 | Alan Armstrong | BSX | Boston Scientific Corp. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | REGN | Regeneron Pharmaceuticals, Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | TEVA | Teva Pharmaceutical Industries Ltd. | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | TAK | Takeda Pharmaceutical Co. Ltd. | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | SNN | Smith & Nephew plc | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | PHG | Koninklijke Philips N.V. | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | GMAB | Genmab A/S | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | FSNUY | Fresenius SE & Co. Kgaa | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | FMS | Fresenius Medical Care AG | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | ARGX | Argenx SE | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | ALC | Alcon Inc. | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | UHS | Universal Health Services Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | DVA | Davita Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | ZBH | Zimmer Biomet Holdings, Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | VRTX | Vertex Pharmaceuticals Inc. / Ma | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | COO | Cooper Companies, Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | SOLV | Solventum Corp. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | RMD | Resmed Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | DGX | Quest Diagnostics Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | MDT | Medtronic plc | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | LH | Labcorp Holdings Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | ISRG | Intuitive Surgical Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | HCA | Hca Healthcare, Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | GILD | Gilead Sciences, Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | GEHC | Ge Healthcare Technologies Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | EW | Edwards Lifesciences Corp. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | BMY | Bristol Myers Squibb Co. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | BIIB | Biogen Inc. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | BDX | Becton Dickinson & Co. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | MMM | 3M Co. | BUY | 2026-03-27 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | JNJ | Johnson & Johnson | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | NVS | Novartis AG | BUY | 2026-03-31 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | AZN | Astrazeneca plc | BUY | 2026-03-31 | $1K–$15K | Health | ↗ eFD |
| 75 | Alan Armstrong | DGX | Quest Diagnostics Inc. | BUY | 2026-03-30 | $1K–$15K | Health | ↗ eFD |